SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

CytomX Announces Milestone Achievement in Regeneron Collaboration

CytomX Therapeutics announced a milestone achievement in its strategic collaboration with Regeneron involving conditionally activated bispecifics.

CTMX

Related stories